{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:55:24Z","timestamp":1787500524703,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":241,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine Open"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.gimo.2024.101891","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:50:27Z","timestamp":1725929427000},"page":"101891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prospective characterization of early symptom onset and progression in young pediatric patients with variants in the GLA gene across 5 years: Longitudinal data from the Fabry MOPPet Study"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8344-8078","authenticated-orcid":false,"given":"D.A.","family":"Laney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Houde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.S.","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.P.","family":"Manwaring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.K.","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Heese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Holida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Quillin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Auray-Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Hopkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gimo.2024.101891_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3733","article-title":"Alpha-galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"issue":"9","key":"10.1016\/j.gimo.2024.101891_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"Eng","year":"2006","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gimo.2024.101891_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gimo.2024.101891_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang","year":"2007","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.gimo.2024.101891_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106967","article-title":"Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: an analysis from the Fabry Registry","volume":"138","author":"Hopkin","year":"2023","journal-title":"Mol Genet Metab"},{"issue":"12","key":"10.1016\/j.gimo.2024.101891_bib6","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.clinthera.2020.10.007","article-title":"Effects of baseline left ventricular hypertrophy and decreased renal function on cardiovascular and renal outcomes in patients with Fabry disease treated with agalsidase alfa: a Fabry outcome survey study","volume":"42","author":"Feriozzi","year":"2020","journal-title":"Clin Ther"},{"issue":"1-2","key":"10.1016\/j.gimo.2024.101891_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymgme.2016.06.007","article-title":"Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: data from the Fabry Registry","volume":"119","author":"Hopkin","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"7","key":"10.1016\/j.gimo.2024.101891_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg-2022-108669","article-title":"Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes","volume":"60","author":"Hughes","year":"2023","journal-title":"J\u00a0Med Genet"},{"issue":"5","key":"10.1016\/j.gimo.2024.101891_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","article-title":"Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria","volume":"51","author":"T\u00f8ndel","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.gimo.2024.101891_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jpeds.2007.09.007","article-title":"Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease","volume":"152","author":"Wraith","year":"2008","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.gimo.2024.101891_bib11","first-page":"1664","article-title":"Biomarkers in Fabry disease. implications for clinical diagnosis and follow-up","volume":"10","author":"Carnicer-C\u00e1ceres","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.gimo.2024.101891_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/gim.2014.120","article-title":"Fabry disease in infancy and early childhood: a systematic literature review","volume":"17","author":"Laney","year":"2015","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.gimo.2024.101891_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","article-title":"Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry","volume":"64","author":"Hopkin","year":"2008","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.gimo.2024.101891_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajmg.c.31998","article-title":"Newborn screening for Fabry disease in Oregon: approaching the iceberg of A143T and variants of uncertain significance","volume":"190","author":"Viall","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"10.1016\/j.gimo.2024.101891_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijns9020031","article-title":"Newborn screening for Fabry disease: current status of knowledge","volume":"9","author":"Gragnaniello","year":"2023","journal-title":"Int J Neonatal Screen"},{"issue":"Database issue","key":"10.1016\/j.gimo.2024.101891_bib16","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.gimo.2024.101891_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/jhg.2011.31","article-title":"Fabry-database.org: database of the clinical phenotypes, genotypes and mutant \u03b1-galactosidase A structures in Fabry disease. Fabry-database.org","volume":"56","author":"Saito","year":"2011","journal-title":"J\u00a0Hum Genet"},{"issue":"6","key":"10.1016\/j.gimo.2024.101891_bib18","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/bioinformatics\/bty742","article-title":"MOLGENIS research: advanced bioinformatics data software for non-bioinformaticians","volume":"35","author":"van der Velde","year":"2019","journal-title":"Bioinformatics"},{"issue":"1-2","key":"10.1016\/j.gimo.2024.101891_bib19","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.ymgme.2016.11.082","article-title":"The Fabry disease genotype-phenotype database (dbFGP): an international expert consortium","volume":"120","author":"Desnick","year":"2017","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.gimo.2024.101891_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.mpg.0000172748.64103.33","article-title":"Development and preliminary validation of the Questionnaire on Pediatric gastrointestinal Symptoms to assess functional gastrointestinal disorders in children and adolescents","volume":"41","author":"Caplan","year":"2005","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.gimo.2024.101891_bib21","first-page":"293","article-title":"The FLACC: a behavioral scale for scoring postoperative pain in young children","volume":"23","author":"Voepel-Lewis","year":"1997","journal-title":"Pediatr Nurs"},{"issue":"8","key":"10.1016\/j.gimo.2024.101891_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.gimo.2024.101891_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ymgme.2009.04.009","article-title":"Fabry disease urinary globotriaosylceramide\/creatinine biomarker evaluation by liquid chromatography-tandem mass spectrometry in healthy infants from birth to 6 months","volume":"97","author":"Barr","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.gimo.2024.101891_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cca.2014.08.002","article-title":"Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry","volume":"438","author":"Auray-Blais","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.gimo.2024.101891_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymgme.2007.10.001","article-title":"Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease","volume":"93","author":"Auray-Blais","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.gimo.2024.101891_bib26","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/ac203433e","article-title":"Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics","volume":"84","author":"Auray-Blais","year":"2012","journal-title":"Anal Chem"},{"issue":"3","key":"10.1016\/j.gimo.2024.101891_bib27","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/ac303033v","article-title":"Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry","volume":"85","author":"Lavoie","year":"2013","journal-title":"Anal Chem"},{"issue":"17","key":"10.1016\/j.gimo.2024.101891_bib28","article-title":"Fabry disease biomarkers: analysis of urinary lyso-Gb3 and seven related analogs using tandem mass spectrometry","volume":"90","author":"Lavoie","year":"2016","journal-title":"Curr Protoc Hum Genet"},{"issue":"457","key":"10.1016\/j.gimo.2024.101891_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.2008.00658.x","article-title":"Fabry disease during childhood: clinical manifestations and treatment with agalsidase alfa","volume":"97","author":"Ramaswami","year":"2008","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.gimo.2024.101891_bib30","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2147\/DDDT.S102761","article-title":"An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are na\u00efve to enzyme replacement therapy","volume":"10","author":"Goker-Alpan","year":"2016","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.gimo.2024.101891_bib31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13023-022-02392-9","article-title":"Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry","volume":"17","author":"Beck","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.gimo.2024.101891_bib32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cca.2015.06.003","article-title":"Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma","volume":"447","author":"Ferreira","year":"2015","journal-title":"Clin Chim Acta"}],"container-title":["Genetics in Medicine Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774424010379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774424010379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T04:11:32Z","timestamp":1735272692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949774424010379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":32,"alternative-id":["S2949774424010379"],"URL":"https:\/\/doi.org\/10.1016\/j.gimo.2024.101891","relation":{},"ISSN":["2949-7744"],"issn-type":[{"value":"2949-7744","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective characterization of early symptom onset and progression in young pediatric patients with variants in the GLA gene across 5 years: Longitudinal data from the Fabry MOPPet Study","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gimo.2024.101891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"101891"}}